Innoviva (INVA) Common Equity (2010 - 2026)
Innoviva (INVA) recorded Common Equity of $1.23 billion in Q2 2026, up 72.5% from $714.82 million a year earlier but down 8.1% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Innoviva reported Common Equity of $1.17 billion, up 69.7% from FY2024.
- Annual Common Equity has increased for four straight years, with a five-year compound annual growth rate of 14.0% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $691.16 million in FY2024 (+2.4%), $674.96 million in FY2023 (+19.3%), $565.79 million in FY2022 (+7.6%) and $525.94 million in FY2021 (-13.5%).
- Quarterly Common Equity has ranged from $491.81 million in Q3 2021 to $1.34 billion in Q1 2026 over the past five years.
- On a year-over-year basis, Common Equity has increased for five consecutive quarters, with growth averaging 43.2% over the last seven quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 107.4% in Q1 2026, against a decline of 20.7% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.34 billion (Q1 2026), $1.17 billion (Q4 2025) and $1.01 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Innoviva | 1.54 Bn | -748.67 Mn | 90.62 Mn | 1.23 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 Bn |
| Mar 31, 2026 | 1.34 Bn |
| Dec 31, 2025 | 1.17 Bn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 714.82 Mn |
| Mar 31, 2025 | 646.91 Mn |
| Dec 31, 2024 | 691.16 Mn |
| Sep 30, 2024 | 668.54 Mn |
| Jun 30, 2024 | 665.52 Mn |
| Mar 31, 2024 | 703.68 Mn |
| Dec 31, 2023 | 674.96 Mn |
| Sep 30, 2023 | 627.49 Mn |
| Jun 30, 2023 | 555.09 Mn |
| Mar 31, 2023 | 561.49 Mn |
| Dec 31, 2022 | 565.79 Mn |
| Sep 30, 2022 | 641.37 Mn |
| Jun 30, 2022 | 565.46 Mn |
| Mar 31, 2022 | 552.22 Mn |
| Dec 31, 2021 | 525.94 Mn |
| Sep 30, 2021 | 491.81 Mn |
API Access
Innoviva Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();